For learning clinical reasoning and educational purpose use only — not a diagnostic or clinical decision-support tool.
Vibe Rounds — Clinical Decision Science · Interactive Decision Lab
Case source ↗
Clinical Decision Science · Interactive Decision Lab

Unfold the mystery: why doesn't one diagnosis explain a lifetime of "everything"?

Every box below is a real fork this patient's clinicians (and her own self-research) faced across four decades of edema, hemolytic-range fatigue, migraines-with-aura, and a transient stroke-like episode. Click an option to test your reasoning against the rationale, the tempting pitfall, the evidence, and — for a patient this let-down by prior medical care — what shared decision-making actually requires.

Age / Sex
42F
Presenting pattern
Lifelong episodic edema, fatigue, migraine w/ aura
Confirmed genetics
G6PD (Seattle), AMPD1 het
Working leads
VUS: GSD type III / IX
Acute red-flag episode
Transient dysarthria + facial droop
Confirmed 2020
Behçet's disease
Low-resource setting
Legend Clinical importance Time urgency Click any option to reveal rationale + pitfall. Use Solve for me for the expert path. Toggle Low-resource setting to see the pragmatic alternative when genetic testing/specialist referral aren't available.

Differential tracker

Updates live as you (or "Solve for me") make choices — this case is unusual because several of these are true simultaneously, not mutually exclusive.

Clinical Decision Science · Learner Map Set

Four decades of "everything": mapping the decisions behind a multi-gene interaction case

A 42-year-old woman with lifelong episodic edema, chronic fatigue, migraine with aura, and a transient stroke-like episode, against a backdrop of confirmed G6PD (Seattle variant) and AMPD1 deficiency, VUS findings for glycogen storage disease, and a 2020 diagnosis of Behçet's disease. Each map below isolates one decision point actually faced across her history.

Age / Sex
42F
Core pattern
Episodic edema + fatigue, lifelong
Acute flag
Transient dysarthria + facial droop
Confirmed genetics
G6PD (Seattle), AMPD1 het
Working lead
VUS: GSD type III / IX
Confirmed 2020
Behçet's disease
How to read each map Clinical Importance (1–5) — how much this decision changes management or outcome Time Urgency (1–5) — how quickly the decision must be acted on Node colors: teal = action/data-gather, amber = decision branch, red = red-flag/critical check, green = endpoint
MAP 01

First minutes — triaging the new neurological episode

Before folding this into her chronic pattern, the clinician must decide whether it's something time-critical.

Large map — acute triage logicIs this "more of the same," or a new time-critical event?
Importance 5/5
Urgency 5/5
Spinning, stuttering, transient left face/arm weakness, worst-ever headache, then a 'pop' + clear fluid from left nostril x10 min
↓
Stroke-mimic screenUnilateral weakness + speech disturbance?Meets FAST criteria — image urgently
CSF-leak screenUnilateral clear rhinorrhea after headstrike-like 'pop'?Beta-2 transferrin workup indicated
↓
Tempting anchor: "her baseline labs/scans are always normal" → do NOT let chronic history lower urgency for a genuinely new, focal symptom set.
↓
Decision: urgent stroke-protocol imaging + targeted CSF-leak workup, independent of her chronic history — hemiplegic migraine stays on the differential, but only after red flags are excluded
Teaching point: a noisy chronic history is a reason to widen the differential, never a reason to lower urgency for a new focal neurological symptom.
MAP 02–03

Two history forks shaped by prior medical trauma

Small, focused maps — each a fork a clinician must recognize while rebuilding trust with this patient.

Small map — infancy, retrospectivelyWeight swings + edema + abnormal liver labs: neglect or metabolic disease?
Importance 4/5
Urgency 4/5
Infant: severe jaundice, refuses all but water/salty broth, episodic facial/abdominal edema, wild weight swings, abnormal liver labs
↓
Parents accused of abuse based on liver labs (misread as alcohol exposure) — custody lostSocial explanation adopted as default
↓
Run metabolic/genetic work-up in parallel with any safeguarding assessment — never as an either/or
↓
Decision (decades later, in hindsight): pattern consistent with inherited metabolic disorder — G6PD, AMPD1, probable GSD — not confirmed until adulthood
Why this is easy to miss: safeguarding concern and organic disease can look identical on the surface; anchoring on one forecloses the other for decades.
Small map — self-research as dataPatient-found VUS genes: dismiss, or investigate together?
Importance 5/5
Urgency 2/5
Patient independently identifies GSD type III/IX VUS genes matching her lifelong phenotype
↓
History of being disbelieved (wrongful anorexia diagnosis, tube-feeding, custody loss) shapes how safe she feels sharing thisTrust has to be actively rebuilt
↓
Review VUS findings collaboratively; neither accept nor dismiss without independent verification (biopsy, specialist)
↓
Decision: treat her research as a testable hypothesis worth formal follow-up, restoring some agency in a relationship that previously overrode her
MAP 04

Reframing the multi-trigger edema pattern

Smoke, exercise, stress, specific foods, sometimes nothing — how a "confusing allergy" becomes a coherent mechanism.

Large map — mechanism, not allergen, firstWhat actually connects this many different triggers?
Importance 4/5
Urgency 3/5
Repeated negative allergy testing, yet swelling with smoke, exertion, stress, specific foods
↓
Force an IgE-allergy framework, or look for a shared underlying pathway?
IgE frameworkDoesn't fit — testing negative repeatedly
Oxidative-stress frameworkG6PD limits NADPH/glutathione defense; AMPD1 affects energy-dependent ion transport — both plausibly converge on edema
↓
Decision: reframe around shared mechanism rather than allergen-chasing or defaulting to a psychiatric explanation
Teaching point: when a pattern doesn't fit the first framework tried, the right move is to change the framework, not to force-fit the data or dismiss it as unexplained/psychosomatic.
MAP 05

New drug decisions in a G6PD-deficient patient

Behçet's is confirmed. Colchicine is first-line. Her G6PD status changes how that decision gets made.

Small map — drug safety screeningGuideline first-line drug, but is it G6PD-safe for her specifically?
Importance 5/5
Urgency 4/5
Behçet's confirmed → colchicine indicated per guideline
↓
Cross-check against her specific G6PD variant before prescribingDon't assume "not classically flagged" = safe
↓
Decision: standing rule — every new agent gets a G6PD-safety check, discussed with her directly, before it starts
Why this is easy to miss: it's tempting to treat "guideline first-line" as interchangeable with "safe for this patient" — her chart requires an extra explicit step every time.
Small map — diet as diagnostic trialPersistent ketosis despite carbs: restriction, or a real metabolic signal?
Importance 4/5
Urgency 2/5
Ketosis persists even on days with fruit/cake — physiologically unexpected
↓
Take symptom report at face value, or track objective markers (ketone strips, CRP, ALT, weight/edema)?History of eating-disorder misdiagnosis raises the stakes of getting this right
↓
Decision: pair the diet trial with objective tracking — turns "I feel better" into interpretable evidence for or against the GSD hypothesis
MAP 06

The whole case as one decision spine

A single large map stringing the prior decisions together in sequence, for revision.

Large map — full case spineFour decades of symptoms to a working, multi-diagnosis picture, in one line of decisions
Importance 5/5
Urgency 4/5
1. Triage acute neuro episode as time-critical
2. Reassess infancy pattern: metabolic work-up alongside safeguarding
3. Rebuild trust; treat self-research as data
4. Flag anesthesia-awareness history before any procedure
5. Hold GSD VUS as hypothesis, not diagnosis
↓
6. Reframe multi-trigger edema around oxidative stress → 7. Screen every new drug against G6PD status → 8. Track diet trial with objective markers → 9. Run a structured interim plan while the one specialist who understood this case is gone
How to use this map: each numbered step corresponds to one of Maps 01–05 above. A learner who can explain why step 1's urgency doesn't change because of steps 2–9's complexity — and why step 5's uncertainty doesn't excuse skipping step 8's tracking — has understood the case.